| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2021 | YCBD Cbdmd, Inc. | Kennedy Thomas Ronan | CFO &COO | Buy | 7,400 | $2.04 | $15,096.00 | New | -27.1% | -78.3% | |
| Aug 24, 2021 | DVAX Dynavax Technologies Corp | Burgess Justin60 | Principal Accounting Officer | Sell | 5,768 | $15.00 | $86,520.00 | -60.8% | +7.5% | -23.3% | |
| Aug 24, 2021 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 10,000 | $14.00 | $140,000.00 | -8.8% | +7.5% | -23.3% | |
| Aug 23, 2021 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $205.82 | $1,234,901.35 | -5.1% | -3.9% | +9.5% | |
| Aug 23, 2021 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 9,603 | $207.07 | $1,988,493.87 | -15.8% | +8.8% | -20.8% | |
| Aug 23, 2021 | ZTS Zoetis Inc. | Reed Willie M55 | Director | Sell | 1,450 | $207.10 | $300,295.00 | -19.6% | +8.8% | -20.8% | |
| Aug 23, 2021 | ALKS Alkermes Plc. | Alva Emily Peterson | Director | Buy | 1,650 | $30.22 | $49,860.40 | New | -24.8% | -17.1% | |
| Aug 20, 2021 | ETON Eton Pharmaceuticals, Inc. | Brynjelsen Sean | President &CEO | Buy | 10,000 | $4.32 | $43,200.00 | +1.0% | +2.5% | -47.2% | |
| Aug 20, 2021 | ETON Eton Pharmaceuticals, Inc. | Troutman William Wilson | CFO, Treasurer &Secretary | Buy | 5,000 | $4.43 | $22,150.00 | +27.7% | +2.5% | -47.2% | |
| Aug 19, 2021 | ALKS Alkermes Plc. | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 40,000 | $29.99 | $1,199,600.00 | -48.2% | -22.3% | -15.2% | |
| Aug 19, 2021 | HROW Harrow, Inc. | Opaleye Management Inc.60 | - | Buy | 52,500 | $8.45 | $443,362.50 | +1.6% | +29.4% | +1.8% | |
| Aug 19, 2021 | OGN Organon & Co. | Francisco Ma. Fatima53 | Director | Buy | 3,000 | $33.79 | $101,370.00 | New | -2.6% | -6.2% | |
| Aug 18, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 15,430 | $274.31 | $4,232,603.30 | - | -3.7% | +19.6% | |
| Aug 18, 2021 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 72,500 | $8.62 | $624,697.15 | +1.1% | +24.3% | -2.4% | |
| Aug 18, 2021 | TXMD Therapeuticsmd, Inc. | Collins Cooper C. | Director | Buy | 1,000,000 | $0.73 | $725,000.00 | +174.3% | -18.3% | -71.6% | |
| Aug 18, 2021 | HIMS Hims & Hers Health, Inc. | Wells David B51 | Director | Buy | 360,000 | $8.24 | $2,965,191.00 | +47.4% | +11.1% | -13.4% | |
| Aug 17, 2021 | TCNNF Trulieve Cannabis Corp. | D'amico Alex | Chief Financial Officer | Buy | 660 | $27.00 | $17,820.00 | +30.6% | - | - | |
| Aug 17, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 3,060 | $274.08 | $838,697.96 | - | -4.9% | +17.8% | |
| Aug 17, 2021 | ORGO Organogenesis Holdings Inc. | Katz Michael W | 10% Owner | Buy | 12,000 | $13.55 | $162,600.00 | +32.2% | -21.2% | -67.6% | |
| Aug 17, 2021 | TXMD Therapeuticsmd, Inc. | Ling Karen | Director | Buy | 33,445 | $0.75 | $25,083.75 | +34.5% | -20.2% | -73.4% | |
| Aug 16, 2021 | DVAX Dynavax Technologies Corp | Janssen Robert71 | Senior Vice President | Sell | 2,917 | $12.36 | $36,054.12 | -26.1% | +40.8% | +17.6% | |
| Aug 16, 2021 | IRWD Ironwood Pharmaceuticals Inc | Silver Ronald68 | Principal Accounting Officer | Sell | 567 | $13.48 | $7,643.16 | -0.9% | -8.8% | -10.2% | |
| Aug 16, 2021 | TCNNF Trulieve Cannabis Corp. | Rivers Kim A. | President And CEO | Buy | 3,509 | $27.91 | $97,925.84 | +2.2% | - | - | |
| Aug 16, 2021 | TXMD Therapeuticsmd, Inc. | Bisaro Paul | Director | Buy | 50,000 | $0.79 | $39,500.00 | +34.0% | -21.5% | -75.4% | |
| Aug 16, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 6,589 | $19.35 | $127,524.16 | -5.9% | +9.4% | +68.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.